CORC

在结果中检索

CORC

浏览/检索结果: 共230条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23
Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11
作者:  Zhang, Yanqiang;  Xu, Xiaoqing;  Hu, Can;  Du, Yian;  Ding, Guangyu
收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23
Maintenance endocrine therapy prolonged progression-free survival of first-line chemotherapy with trastuzumab in advanced HR-positive, HER2-positive breast cancer patients. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Fang, Zi-Ru;  Li, Guang-Liang
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Fang, Zi-Ru;  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Shao, Xi-Ying
收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23
Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores 期刊论文
ADVANCED MATERIALS TECHNOLOGIES, 2022
作者:  Hu, Rui;  Lu, Wenlong;  Wei, Guanghao;  Nan, Hexin;  Li, Juan
收藏  |  浏览/下载：9/0  |  提交时间：2022/12/23
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载：92/0  |  提交时间：2022/03/28
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future 期刊论文
MOLECULAR IMAGING AND BIOLOGY, 2022, 页码: 16
作者:  Cheng, Zhongquan;  Du, Yang;  Yu, Leyi;  Yuan, Zhu;  Tian, Jie
收藏  |  浏览/下载：43/0  |  提交时间：2022/03/17
A homogeneous time-resolved fluorometric energy transfer assay for the binding assessment of FcRn with IgG antibodies 期刊论文
JOURNAL OF IMMUNOLOGICAL METHODS, 2021, 卷号: 499, 页码: 6
作者:  Song, Yakai;  Deng, Xiaojie;  Shi, Wei;  Tang, Feng;  Huang, Wei
收藏  |  浏览/下载：19/0  |  提交时间：2022/01/04

©版权所有 ©2017 CSpace - Powered by CSpace